Duloxetine treatment of social anxiety disorder with comorbid major depression

Journal of Clinical Psychopharmacology

Volumn 28, Issue 5, 2008, Pages 591-592

  Lin, Chao Cheng ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; FLUOXETINE; VENLAFAXINE; ADRENERGIC RECEPTOR AFFECTING AGENT; SEROTONIN UPTAKE INHIBITOR; THIOPHENE DERIVATIVE;

ADULT; CASE REPORT; COMORBIDITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; MAJOR DEPRESSION; NAUSEA; PATIENT SATISFACTION; PRIORITY JOURNAL; RATING SCALE; SELF REPORT; SOCIAL PHOBIA; SOCIAL PHOBIA INVENTORY; ANXIETY DISORDER; FOLLOW UP; MIDDLE AGED; NOTE;

ADRENERGIC UPTAKE INHIBITORS; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 58149109325     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318185a705     Document Type: Letter

References (9)

1. Crippa JA, Filho AS, Freitas MC, et al. Duloxetine in the treatment of social anxiety disorder. J Clin Psychopharmacol. 2007; 27:310.
2. Gau SS, Chong MY, Chen TH, et al. A 3-year panel study of mental disorders among adolescents in Taiwan. Am JPsychiatry. 2005; 162:1344-1350.
3. Kilian R, Dietrich S, Toumi M, et al. Quality of life in persons with schizophrenia in out-patient treatment with first- or second- generation antipsychotics. Acta Psychiatr Scand. 2004;110:108-118.
4. Narrow WE, Rae DS, Robins LN, et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry. 2002; 59:115-123.
5. Offord DR, Boyle MH, Campbell D, et al. One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry. 1996;41:559-563.
6. Fava M, Rankin MA, Wright EC, et al. Anxiety disorders in major depression. Compr Psychiatry. 2000;41:97-102.
7. Pini S, Cassano GB, Simonini E, et al. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord. 1997;42:145-153.
8. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54: 573-583.
9. Connor KM, Davidson JR, Churchill LE, et al. Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br J Psychiatry. 2000;176:379-386. 10. Schneier FR, Blanco C, Campeas R, et al. Citalopram treatment of social anxiety disorder with comorbid major depression. Depress Anxiety. 2003;17:191-196.